(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Hostess Brands, Summit Therapeutics plc, and ToughBuilt Industries.
Rank | Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|---|
1 | Hostess Brands (TWNKW) | 3.20 | 41.59% | 2023-06-22 13:14:07 |
2 | Summit Therapeutics plc (SMMT) | 2.81 | 14.23% | 2023-06-22 01:17:07 |
3 | ToughBuilt Industries (TBLT) | 0.29 | 11.84% | 2023-06-22 09:07:07 |
4 | U.S. Gold Corp (USAU) | 4.72 | 10.28% | 2023-06-22 10:31:11 |
5 | Seanergy Maritime Holdings Corp (SHIPW) | 0.03 | 10% | 2023-06-21 23:15:08 |
6 | Stable Road Acquisition Corp. (SRACU) | 12.20 | 8.35% | 2023-06-22 04:41:07 |
7 | Super Micro Computer (SMCI) | 234.96 | 6.84% | 2023-06-22 10:27:39 |
8 | MongoDB (MDB) | 394.52 | 5.78% | 2023-06-22 10:29:55 |
9 | Celsius Holdings (CELH) | 148.38 | 5.63% | 2023-06-22 10:29:09 |
10 | Groupon (GRPN) | 5.06 | 5.21% | 2023-06-22 10:25:16 |
The three biggest losers today are Verb Technology Company, Surgalign Holdings, and Solid Biosciences.
Rank | Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|---|
1 | Verb Technology Company (VERBW) | 0.01 | -36.88% | 2023-06-22 15:15:08 |
2 | Surgalign Holdings (SRGA) | 0.19 | -13.59% | 2023-06-22 04:44:08 |
3 | Solid Biosciences (SLDB) | 6.12 | -10.33% | 2023-06-22 01:10:08 |
4 | Gyrodyne (GYRO) | 10.53 | -9.92% | 2023-06-22 10:10:33 |
5 | Marathon (MARA) | 11.16 | -8.6% | 2023-06-22 10:26:13 |
6 | iRobot (IRBT) | 45.35 | -8.43% | 2023-06-22 10:25:53 |
7 | Canaan (CAN) | 2.02 | -7.99% | 2023-06-22 10:29:06 |
8 | AMC (AMC) | 4.17 | -7.95% | 2023-06-22 10:17:42 |
9 | Veritone (VERI) | 4.16 | -7.76% | 2023-06-22 15:23:09 |
10 | Repare Therapeutics (RPTX) | 11.58 | -7.58% | 2023-06-21 19:47:07 |
Winners today
1. Hostess Brands (TWNKW) – 41.59%
Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States. It primarily offer a range of snack cakes, donuts, sweet rolls, breakfast pastries, snack pies, and related products. The company operates in two segments, Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment offers fresh and frozen sweet baked goods and bread products under the Hostess, Dolly Madison, Cloverhill, and Big Texas brands, as well as store branded products. The In-Store Bakery segment primarily provides Superior on Main branded eclairs, madeleines, brownies, and iced cookies in the bakery section of grocery and club stores. The company was formerly known as Gores Holdings, Inc. and changed its name to Hostess Brands, Inc. in November 2016. Hostess Brands, Inc. was founded in 1919 and is based in Lenexa, Kansas.
NASDAQ ended the session with Hostess Brands jumping 41.59% to $3.20 on Thursday, after five sequential sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
PE Ratio
Hostess Brands has a trailing twelve months price to earnings ratio of 5.15. Meaning, the purchaser of the share is investing $5.15 for every dollar of annual earnings.
Yearly Top and Bottom Value
Hostess Brands’s stock is valued at $3.20 at 17:32 EST, way under its 52-week high of $4.02 and way higher than its 52-week low of $1.12.
More news about Hostess Brands.
2. Summit Therapeutics plc (SMMT) – 14.23%
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
NASDAQ ended the session with Summit Therapeutics plc jumping 14.23% to $2.81 on Thursday while NASDAQ jumped 0.95% to $13,630.61.
Earnings Per Share
As for profitability, Summit Therapeutics plc has a trailing twelve months EPS of $-2.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -606.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Summit Therapeutics plc’s EBITDA is 3.47.
More news about Summit Therapeutics plc.
3. ToughBuilt Industries (TBLT) – 11.84%
ToughBuilt Industries, Inc. designs, develops, manufactures, and distributes home improvement and construction products for the building industry in the United States and internationally. It offers tool pouches, tool rigs, tool belts and accessories, tools bags, totes, various storage solutions, and office organizers/bags for laptop/tablet/cellphones, etc.; and kneepads. The company also provides sawhorses, miter saws, table saws, roller stands, and workbenches; sawhorse/jobsite tables; and digital measure and levels. It offers its products under the TOUGHBUILT brand through various home improvement big box stores, professional outlets, and direct marketing to construction companies and trade/wholesale outlets. The company was formerly known as Phalanx, Inc. and changed its name to ToughBuilt Industries, Inc. in December 2015. ToughBuilt Industries, Inc. was incorporated in 2012 and is based in Lake Forest, California.
NASDAQ ended the session with ToughBuilt Industries jumping 11.84% to $0.29 on Thursday while NASDAQ jumped 0.95% to $13,630.61.
Earnings Per Share
As for profitability, ToughBuilt Industries has a trailing twelve months EPS of $4.36.
PE Ratio
ToughBuilt Industries has a trailing twelve months price to earnings ratio of 0.07. Meaning, the purchaser of the share is investing $0.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.38%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ToughBuilt Industries’s EBITDA is 0.12.
More news about ToughBuilt Industries.
4. U.S. Gold Corp (USAU) – 10.28%
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.
NASDAQ ended the session with U.S. Gold Corp jumping 10.28% to $4.72 on Thursday while NASDAQ rose 0.95% to $13,630.61.
Earnings Per Share
As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-0.87.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.37%.
Moving Average
U.S. Gold Corp’s worth is above its 50-day moving average of $4.47 and way higher than its 200-day moving average of $4.27.
Earnings Before Interest, Taxes, Depreciation, and Amortization
U.S. Gold Corp’s EBITDA is -15.32.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, U.S. Gold Corp’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for U.S. Gold Corp is 455307 which is 216.46% above its average volume of 143874.
More news about U.S. Gold Corp.
5. Seanergy Maritime Holdings Corp (SHIPW) – 10%
NASDAQ ended the session with Seanergy Maritime Holdings Corp rising 10% to $0.03 on Thursday, after five consecutive sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.
PE Ratio
Seanergy Maritime Holdings Corp has a trailing twelve months price to earnings ratio of 0.21. Meaning, the purchaser of the share is investing $0.21 for every dollar of annual earnings.
Yearly Top and Bottom Value
Seanergy Maritime Holdings Corp’s stock is valued at $0.03 at 17:32 EST, below its 52-week high of $0.03 and higher than its 52-week low of $0.03.
More news about Seanergy Maritime Holdings Corp.
6. Stable Road Acquisition Corp. (SRACU) – 8.35%
NASDAQ ended the session with Stable Road Acquisition Corp. jumping 8.35% to $12.20 on Thursday, after two consecutive sessions in a row of gains. NASDAQ rose 0.95% to $13,630.61, after three consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Moving Average
Stable Road Acquisition Corp.’s worth is above its 50-day moving average of $12.08 and way below its 200-day moving average of $15.74.
Yearly Top and Bottom Value
Stable Road Acquisition Corp.’s stock is valued at $12.20 at 17:32 EST, way under its 52-week high of $35.00 and way above its 52-week low of $9.78.
Volume
Today’s last reported volume for Stable Road Acquisition Corp. is 1893 which is 4.58% above its average volume of 1810.
More news about Stable Road Acquisition Corp..
7. Super Micro Computer (SMCI) – 6.84%
Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company also provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. Super Micro Computer, Inc. was incorporated in 1993 and is headquartered in San Jose, California.
NASDAQ ended the session with Super Micro Computer rising 6.84% to $234.96 on Thursday, after four consecutive sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Super Micro Computer has a trailing twelve months EPS of $10.23.
PE Ratio
Super Micro Computer has a trailing twelve months price to earnings ratio of 22.97. Meaning, the purchaser of the share is investing $22.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.6%.
Moving Average
Super Micro Computer’s value is way higher than its 50-day moving average of $146.43 and way above its 200-day moving average of $95.85.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Super Micro Computer’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 6.5% and a negative 21.6%, respectively.
Volatility
Super Micro Computer’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.53%, a positive 1.57%, and a positive 3.91%.
Super Micro Computer’s highest amplitude of average volatility was 3.53% (last week), 4.54% (last month), and 3.91% (last quarter).
More news about Super Micro Computer.
8. MongoDB (MDB) – 5.78%
MongoDB, Inc. provides general purpose database platform worldwide. The company offers MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.
NASDAQ ended the session with MongoDB jumping 5.78% to $394.52 on Thursday, after three successive sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, MongoDB has a trailing twelve months EPS of $-4.71.
More news about MongoDB.
9. Celsius Holdings (CELH) – 5.63%
Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. It also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened name; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery distributors and direct to retailers, include supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.
NASDAQ ended the session with Celsius Holdings rising 5.63% to $148.38 on Thursday, after three sequential sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Celsius Holdings has a trailing twelve months EPS of $-2.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.94%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Celsius Holdings’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 94.9%, now sitting on 780.16M for the twelve trailing months.
Volatility
Celsius Holdings’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.01%, a positive 0.35%, and a positive 2.08%.
Celsius Holdings’s highest amplitude of average volatility was 1.01% (last week), 2.33% (last month), and 2.08% (last quarter).
Volume
Today’s last reported volume for Celsius Holdings is 611421 which is 43.72% below its average volume of 1086540.
More news about Celsius Holdings.
10. Groupon (GRPN) – 5.21%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon jumping 5.21% to $5.06 on Thursday while NASDAQ rose 0.95% to $13,630.61.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-6.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -285.15%.
More news about Groupon.
Losers Today
1. Verb Technology Company (VERBW) – -36.88%
NASDAQ ended the session with Verb Technology Company sliding 36.88% to $0.01 on Thursday while NASDAQ rose 0.95% to $13,630.61.
Yearly Top and Bottom Value
Verb Technology Company’s stock is valued at $0.01 at 17:32 EST, below its 52-week low of $0.01.
More news about Verb Technology Company.
2. Surgalign Holdings (SRGA) – -13.59%
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
NASDAQ ended the session with Surgalign Holdings falling 13.59% to $0.19 on Thursday while NASDAQ jumped 0.95% to $13,630.61.
Earnings Per Share
As for profitability, Surgalign Holdings has a trailing twelve months EPS of $-1.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1497.02%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 8.9% and a drop 5.1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Surgalign Holdings’s EBITDA is -0.13.
Revenue Growth
Year-on-year quarterly revenue growth declined by 18.7%, now sitting on 78.12M for the twelve trailing months.
More news about Surgalign Holdings.
3. Solid Biosciences (SLDB) – -10.33%
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Solid Biosciences falling 10.33% to $6.12 on Thursday while NASDAQ rose 0.95% to $13,630.61.
Earnings Per Share
As for profitability, Solid Biosciences has a trailing twelve months EPS of $-9.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.13%.
Volume
Today’s last reported volume for Solid Biosciences is 54948 which is 68.43% above its average volume of 32622.
Sales Growth
Solid Biosciences’s sales growth for the current quarter is negative 64.3%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 53.9% and 46.9%, respectively.
More news about Solid Biosciences.
4. Gyrodyne (GYRO) – -9.92%
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
NASDAQ ended the session with Gyrodyne sliding 9.92% to $10.53 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.95% to $13,630.61, after three consecutive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Gyrodyne has a trailing twelve months EPS of $0.21.
PE Ratio
Gyrodyne has a trailing twelve months price to earnings ratio of 50.14. Meaning, the purchaser of the share is investing $50.14 for every dollar of annual earnings.
Volatility
Gyrodyne’s last week, last month’s, and last quarter’s current intraday variation average was 20.00%, 4.42%, and 4.08%.
Gyrodyne’s highest amplitude of average volatility was 20.00% (last week), 5.15% (last month), and 4.08% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Gyrodyne’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Gyrodyne is 771 which is 49.24% below its average volume of 1519.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 2.74M for the twelve trailing months.
More news about Gyrodyne.
5. Marathon (MARA) – -8.6%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon sliding 8.6% to $11.16 on Thursday, after three sequential sessions in a row of gains. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-7.5.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -103.2%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 117.16M for the twelve trailing months.
Moving Average
Marathon’s worth is way above its 50-day moving average of $9.69 and way above its 200-day moving average of $8.62.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 100.6% and 115.4%, respectively.
More news about Marathon.
6. iRobot (IRBT) – -8.43%
iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.
NASDAQ ended the session with iRobot sliding 8.43% to $45.35 on Thursday, after two sequential sessions in a row of losses. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, iRobot has a trailing twelve months EPS of $-14.79.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.8%.
Moving Average
iRobot’s worth is way higher than its 50-day moving average of $38.68 and below its 200-day moving average of $47.08.
Volatility
iRobot’s last week, last month’s, and last quarter’s current intraday variation average was 6.08%, 2.35%, and 1.96%.
iRobot’s highest amplitude of average volatility was 8.05% (last week), 3.28% (last month), and 1.96% (last quarter).
Volume
Today’s last reported volume for iRobot is 1701560 which is 257.02% above its average volume of 476596.
Earnings Before Interest, Taxes, Depreciation, and Amortization
iRobot’s EBITDA is 1.35.
Previous days news about iRobot
- Amazon and the AI war: irobot acquisition in focus. According to FXStreet on Wednesday, 21 June, "The deal to acquire Roomba maker iRobot (NASDAQ: IRBT) is not new; it was announced late last year but is an example of consolidation and acquisition that will likely continue as the AI war grinds on."
More news about iRobot.
7. Canaan (CAN) – -7.99%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan sliding 7.99% to $2.02 on Thursday while NASDAQ rose 0.95% to $13,630.61.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.45.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.4%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canaan’s EBITDA is 0.68.
Volume
Today’s last reported volume for Canaan is 1282530 which is 41.97% below its average volume of 2210230.
More news about Canaan.
8. AMC (AMC) – -7.95%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC dropping 7.95% to $4.17 on Thursday, after five consecutive sessions in a row of losses. NYSE fell 0.36% to $15,600.70, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-0.76.
Volatility
AMC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.67%, a negative 0.52%, and a positive 3.91%.
AMC’s highest amplitude of average volatility was 1.67% (last week), 2.06% (last month), and 3.91% (last quarter).
More news about AMC.
9. Veritone (VERI) – -7.76%
Veritone, Inc. provides artificial intelligence (AI) and computing solutions in the United States and the United Kingdom. It develops and operates aiWARE platform, an AI operating system that integrates and orchestrates a range of cognitive engines to reveal multivariate insights from structured and unstructured data, as well as to conduct cognitive workflows based on these insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, legal and compliance, and government markets The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.
NASDAQ ended the session with Veritone sliding 7.76% to $4.16 on Thursday, following the last session’s downward trend. NASDAQ rose 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Veritone has a trailing twelve months EPS of $-0.77.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.93%.
Sales Growth
Veritone’s sales growth is negative 13.1% for the ongoing quarter and 14% for the next.
Volume
Today’s last reported volume for Veritone is 465288 which is 35.46% below its average volume of 720956.
Moving Average
Veritone’s worth is under its 50-day moving average of $4.31 and way under its 200-day moving average of $6.00.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 10% and positive 93.8% for the next.
More news about Veritone.
10. Repare Therapeutics (RPTX) – -7.58%
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
NASDAQ ended the session with Repare Therapeutics falling 7.58% to $11.58 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.95% to $13,630.61, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Repare Therapeutics has a trailing twelve months EPS of $-0.69.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.47%.
More news about Repare Therapeutics.
Stay up to date with our winners and losers daily report